Bayer Raises Full-Year Earnings Guidance as Pharma Recovers
Bayer said a recovery in its pharmaceutical business helped mitigate market pressures at its agriculture and consumer-health divisions. Shares rose 5.6% in European morning trading.
By Adria CalatayudBayer shares rose after the German group raised its full-year earnings guidance, citing a recovery in its pharmaceutical business that allowed it to mitigate market pressures at its agricultural and consumer-health divisions.Shares in Bayer were up 5.6% in European morning trading…